A stereospecific myo-inositol D-chiro-inositol transporter in HepG2 liver cells - Identification with D-chiro-[3-H-3]inositol

被引:35
|
作者
Ostlund, RE
Seemayer, R
Gupta, S
Kimmel, R
Ostlund, EL
Sherman, WR
机构
[1] WASHINGTON UNIV,SCH MED,DIV METAB,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,DEPT PSYCHIAT,ST LOUIS,MO 63110
[3] GENENCOR INT INC,S SAN FRANCISCO,CA 94080
[4] AMER RADIOLABELED CHEM INC,ST LOUIS,MO 63146
关键词
D O I
10.1074/jbc.271.17.10073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-chiro-Inositol is an epimer of myo-inositol that is found in certain mammalian glycosylphosphatidylinositol protein anchors and inositol phosphoglycans possessing insulin-like bioactivity. In order to generate a probe for metabolic studies, D-chiro-[3-H-3]inositol was synthesized by selective reduction of D-chiro-3-inosose at pH 6.5 with sodium borotritide. D-chiro-[3-H-3]Inositol was taken up by HepG2 human liver cells through a saturable and stereospecific pathway in which D-chiro-inositol and myo-inositol competed equally but L-chiro-inositol was not recognized. D-Glucose, but not L-glucose, competed for D-chiro-[3-H-3]inositol uptake over glucose concentrations of 4-28 mM. Maximum transport capacity was 717 pmol/mg cell protein/3 h with a K-m value of 348 mu M. Uptake was reduced by 76% when sodium was eliminated from the medium and by 94% when the experiment was performed at 0 degrees C. The new myo/D-chiro-inositol transporter is distinct from the sodium-myo-inositol co-transporter found in many tissues and accounts for all of the saturable D-chiro-inositol uptake and for a portion of the saturable low affinity myo-inositol uptake in HepG2 cells. It may allow D-chiro-inositol to be used by cells in the presence of a relatively large amount of competing myo-inositol.
引用
收藏
页码:10073 / 10078
页数:6
相关论文
共 50 条
  • [21] The distribution of D-chiro-inositol in buckwheat and its antioxidative effect in HepG2
    Cheng, Feier
    Ge, Xinhui
    Gao, Caifeng
    Li, Yunlong
    Wang, Min
    JOURNAL OF CEREAL SCIENCE, 2019, 89
  • [22] Myo-Inositol and D-Chiro-Inositol Prevent Palmitate-induced Autophagy and Senescence in Human Cardiac Progenitor Cells
    D'Oria, Rossella
    Laviola, Luigi
    Leonardini, Anna
    Incalza, Maria Angela
    Caccioppoli, Cristina
    Nigro, Pasquale
    Scioscia, Marco
    Natalicchio, Annalisa
    Perrini, Sebastio
    Giorgino, Francesco
    DIABETES, 2015, 64 : A137 - A137
  • [23] Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
    Pizzo, Alfonsa
    Lagana, Antonio Simone
    Barbaro, Luisa
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (03) : 205 - 208
  • [24] Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus
    Aisling Murphy
    Amir Shamshirsaz
    Daniela Markovic
    Richard Ostlund
    Brian Koos
    Reproductive Sciences, 2016, 23 : 365 - 371
  • [25] Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus
    Murphy, Aisling
    Shamshirsaz, Amir
    Markovic, Daniela
    Ostlund, Richard
    Koos, Brian
    REPRODUCTIVE SCIENCES, 2016, 23 (03) : 365 - 371
  • [26] Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology - assisted reproduction technology
    Bevilacqua, Arturo
    Carlomagno, Gianfranco
    Gerli, Sandro
    Oliva, Mario Montanino
    Devroey, Paul
    Lanzone, Antonio
    Soulange, Christophe
    Facchinetti, Fabio
    Di Renzo, Gian Carlo
    Bizzarri, Mariano
    Hod, Moshe
    Cavalli, Pietro
    D'Anna, Rosario
    Benvenga, Salvatore
    Chiu, Tony T.
    Kamenov, Zdravko A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (06) : 441 - 446
  • [27] Increased urinary excretion of myo-inositol and D-chiro-inositol in diabetes occurs independently of hyperglycaemia in the isolated perfused kidney
    Loomes, K. M.
    Choong, B.
    Phillips, A.
    Chang, H. -H.
    DIABETOLOGIA, 2011, 54 : S441 - S441
  • [28] The Role of myo-inositol/D-chiro-inositol in a physiological ratio of 40: 1 in preventing the onset of gestational diabetes mellitus
    Farren, M.
    Daly, N.
    McKeating, A.
    Turner, M. J.
    Daly, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (13) : E3 - E3
  • [29] Metabolic and hormonal effects of a combined Myo-inositol and D-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS)
    Januszewski, Marcin
    Issat, Tadeusz
    Jakimiuk, Alicja A.
    Santor-Zaczynska, Malgorzata
    Jakimiuk, Artur J.
    GINEKOLOGIA POLSKA, 2019, 90 (01) : 7 - 10
  • [30] Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with manganese in streptozotocin diabetic rats
    Fonteles, MC
    Almeida, MQ
    Larner, J
    HORMONE AND METABOLIC RESEARCH, 2000, 32 (04) : 129 - 132